Editing Fibrillary glomerulopathy (MGRS)

{{tp|p=12631361|t=2003. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.|pdf=|usr=}}{{12631361}}
{{tp|p=8372831|t=1993. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.|pdf=|usr=}}{{8372831}}
{{tp|p=37899889|t=2023. DNAJB9 Fibrillary Glomerulonephritis With Membranous-Like Pattern: A Case-Based Literature Review.|pdf=|usr=}}{{37899889}}
{{tp|p=36576710|t=2023. IgA-dominant glomerulonephritis with DNAJB9-negative fibrillar polytypic immunoglobulin deposits in the subepithelium.|pdf=|usr=}}{{36576710}}
{{tp|p=36140202|t=2022. DNAJB9 Is a Reliable Immunohistochemical Marker of Fibrillary Glomerulonephritis: Evaluation of Diagnostic Efficacy in a Large Series of Kidney Biopsies.|pdf=|usr=}}{{36140202}}
{{tp|p=35692803|t=2022. Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges.|pdf=|usr=}}{{35692803}}
{{tp|p=34084464|t=2021. Characteristics of patients with coexisting DNAJB9-associated fibrillary glomerulonephritis and IgA nephropathy.|pdf=|usr=}}{{34084464}}
{{tp|p=33656648|t=2021. Complete remission of DnaJ homolog subfamily B member 9-positive fibrillary glomerulonephritis following steroid monotherapy in an elderly Japanese woman.|pdf=|usr=}}{{33656648}}
{{tp|p=31685544|t=2019. Fibrillary Glomerulonephritis: Clinicopathologic Features and Atypical Cases from a Multi-Institutional Cohort.|pdf=|usr=}}{{31685544}}
{{tp|p=28503551|t=2017. A Case of Fibrillary Glomerulonephritis with Fibril Deposition in the Arteriolar Wall and a Family History of Renal Disease.|pdf=|usr=}}{{28503551}}
{{tp|p=21441134|t=2011. Fibrillary glomerulonephritis: a report of 66 cases from a single institution.|pdf=|usr=}}{{21441134}}
{{tp|p=37284687|t=2023. DNAJB9-Positive Tubulointerstitial-Predominant Fibrillary Nephritis.|pdf=|usr=}}{{37284687}}
{{tp|p=36817290|t=2022. Fibrillary Glomerulonephritis, DNAJB9, and the Unfolded Protein Response.|pdf=|usr=}}{{36817290}}
{{tp|p=36644363|t=2023. Subclass Changes in Fibrillary Glomerulonephritis.|pdf=|usr=}}{{36644363}}
{{tp|p=34011106|t=2021. Clinicopathologic features and treatment outcomes of patients with fibrillary glomerulonephritis: A case series.|pdf=|usr=}}{{34011106}}
{{tp|p=35369552|t=2020. Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9).|pdf=|usr=}}{{35369552}}
{{tp|p=31317113|t=2019. Fibrillary Glomerulonephritis: An Update.|pdf=|usr=}}{{31317113}}
{{tp|p=29340314|t=2018. DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis.|pdf=|usr=}}{{29340314}}
{{tp|p=29097623|t=2018. DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN.|pdf=|usr=}}{{29097623}}
{{tp|p=35692803|t=2022. Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges |pdf=|usr=}}{{35692803}}
{{tp|p=33912743|t=2021. Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction |pdf=|usr=}}{{33912743}}